RxDoctor Payments Data

David Best, DO

Family Medicine · Traverse City, MINPI 1871583195

Payments from drug & device makers

$16,347in general payments, 2019–2025

Across 125 payments — averaging $130.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Indivior Inc.$15K
  • AbbVie$340
  • Alkermes, Inc.$141
  • Sunovion Pharmaceuticals Inc.$134
  • GSK$122
  • Braeburn Inc.$98
  • plus $511 from 13 others

What the payments were for

  • Speaking & faculty fees$11,70072%
  • Travel & lodging$2,00012%
  • Food & beverage$2,62416%
  • Education$230%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,347 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$24,029
Medicare patients
39
Services billed
375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl31$62,716
Trelegy ElliptaFluticasone/Umeclidin/Vilanter75$51,961
OzempicSemaglutide34$41,447
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl183$26,179
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr51$23,540
EliquisApixaban22$13,170
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen310$9,867
Oxycodone Hcl168$9,379
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$9,016
ZubsolvBuprenorphine Hcl/Naloxone Hcl33$7,100
Morphine Sulfate ErMorphine Sulfate191$6,715
Combivent RespimatIpratropium/Albuterol Sulfate14$6,497
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen188$6,362
Buprenorphine Hcl50$3,765
Varenicline Tartrate12$3,393

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$122$75,501126 claims
Novo NordiskOzempic$56$41,44734 claims
Hikma Pharmaceuticals USABuprenorphine-Naloxone, Buprenorphine Hcl, Buprenorphine, Morphine Sulfate$21$34,826300 claims
Orexo US, Inc.Zubsolv$56$7,10033 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Traverse City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →